Back in 2024, on May 14, Mad Money’s Jim Cramer was asked about Moderna, Inc. (NASDAQ:MRNA), explaining that some family ...

The average short interest for the S&P 500 Health Care Index Sector (NYSEARCA:XLV) experienced an increase in April, moving ...

The stock might be down substantially over the past three years, but it isn't out of the picture yet. Teladoc Health is a ...

Therapies involving mRNA, a key to Covid vaccines, hold great potential in treating several diseases, but some lawmakers want ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

A combination shot for flu and Covid-19 using messenger RNA generated antibodies in a study, but US government regulators want to see data on whether the new vaccine protects people from getting sick.

The anti-mRNA sentiment — coupled with the sweeping shake-up of science funding across the United States — has sparked fears ...

Morabaha Marina Financing Co. (MRNA) said it will not be able to release its preliminary financial results for the ...

A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...

A genome-wide association study in Sweden identified rare genetic variants near the SCAF11 and LRRC4C genes that may be ...

GlobalData analysts have tipped the global market for genomic therapies to balloon to almost $90 billion by 2030, driven by ...

K nowing the location of a gene within intact tissue or a single cell allows scientists to unlock unknown cellular functions.